The Journal of Organic Chemistry
Article
2H), 7.23−7.22 (m, 2H), 6.91 (t, J = 7.1 Hz, 1H), 3.39 (d, J = 0.7 Hz,
3H), 2.91 (heptet, J = 7.0 Hz, 1H), 1.26 (d, J = 7.0 Hz, 6H); 13C NMR
(125 MHz, CDCl3) δ 148.6, 147.9, 134.4, 132.0, 128.9, 126.6, 126.1,
120.3, 115.1, 33.9, 32.9, 23.9. HRMS(ESI) m/z calcd for C17 H21N2
[M + H]+ 253.1705, found 253.1700.
125.6, 125.0, 123.9, 120.7, 115.4, 33.1; HRMS(ESI) m/z calcd for
C18H17N2 [M + H]+ 261.1392, found 261.1384.
(E)-1-Methyl-2-(naphthalen-2-ylmethylene)-1-phenylhydrazine
1
(3an). 81% yield (211 mg); mp 178−179 °C; H NMR (500 MHz,
CDCl3) δ 8.07 (dd, J = 8.7 Hz and J = 1.6 Hz, 1H), 7.89 (s, 1H),
7.84−7.81 (m, 3H), 7.66 (s, 1H), 7.48−7.42 (m, 4H), 7.37−7.33 (m,
2H), 6.95 (t, J = 7.3 Hz, 1H), 3.47 (s, 3H); 13C NMR (125 MHz,
CDCl3) δ 147.8, 134.5, 133.6, 133.2, 131.9,129.0, 128.2, 127.9, 127.8,
126.2, 126.1, 125.8, 123.1, 120.6, 115.3, 33.0; HRMS-EI (70 eV) m/z
calcd for C18H16N2 [M + H]+ 261.1392, found 261.1379.
(E)-2-(4-Methoxybenzylidene)-1-methyl-1-phenylhydrazine
(3ae).31 87% yield (209 mg); mp 113−114 °C; H NMR (500 MHz,
1
CDCl3) δ 7.64 (d, J = 8.3 Hz, 2H), 7.48 (s, 1H), 7.37 (d, J = 8.4 Hz,
2H), 7.31 (t, J = 7.6 Hz, 2H), 6.92−6.89 (m, 3H), 3.83 (s, 3H), 3.40
(s, 3H); 13C NMR (125 MHz, CDCl3) δ 159.5, 148.0, 131.9, 129.7,
129.0, 127.3, 120.2, 115.0, 114.0, 55.3, 33.0. HRMS(ESI) m/z calcd for
C15H17N2O [M + H]+ 241.1341, found 241.1332.
(E)-1-Methyl-1-phenyl-2-(thiophen-2-ylmethylene)hydrazine
(3ao).30 87% yield (188 mg); mp 79−80 °C; H NMR (500 MHz,
1
(E)-2-(3,4-Dimethoxybenzylidene)-1-methyl-1-phenylhydrazine
CDCl3) δ 7.68 (s, 1H), 7.35−7.30 (m, 4H), 7.20 (d, J = 5.1 Hz, 1H),
7.09 (d, J = 3.2 Hz, 1H), 7.01−6.99 (m, 1H), 6.92 (tt, J = 6.7 Hz and J
= 1.7 Hz, 1H), 3.39 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 147.5,
142.7, 129.0, 127.1, 126.9, 125.4, 124.8, 120.6, 115.2, 33.2.
(3af).32 85% yield (229 mg); mp 97−98 °C; H NMR (500 MHz,
1
CDCl3) δ 7.47 (s, 1H), 7.40 (s, 1H), 7.37−7.30 (m, 4H), 7.12 (d, J =
8.4 Hz, 1H), 6.92 (t, J = 7.0 Hz, 1H), 6.87 (d, J = 8.3 Hz, 1H), 3.96 (s,
3H), 3.91(s, 3H), 3.42 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 149.3,
149.1, 148.0, 132.0, 130.0, 128.9, 120.2, 119.8, 115.1, 110.9, 107.7,
55.9, 55.8, 33.1.
(E)-2-((2-Methyl-2-phenylhydrazono)methyl)pyridine (3ap).33
1
80% yield (168 mg); oil; H NMR (500 MHz, CDCl3) δ 8.54−8.52
(m, 1H), 8.01 (dt, J = 8.1 Hz and J = 1.0 Hz, 1H), 7.67 (td, J = 7.8 Hz
and J = 1.7 Hz, 1H), 7.62 (s, 1H), 7.41−7.38 (m, 2H), 7.36−7.32 (m,
2H), 7.15−7.12 (m, 1H), 6.98 (tt, J = 7.2 Hz and J = 1.2 Hz, 1H), 3.46
(s, 3H); 13C NMR (125 MHz, CDCl3) δ 155.8, 148.9, 147.4, 136.1,
132.5, 129.0, 121.8, 121.2, 119.0, 115.6, 33.3.
(E)-2-(4-Fluorobenzylidene)-1-methyl-1-phenylhydrazine (3ag).
1
75% yield (170 mg); mp 96−97 °C; H NMR (500 MHz, CDCl3)
δ 7.67 (t, J = 6.8 Hz, 2H), 7.47 (s, 1H), 7.38−7.31 (m, 4H), 7.06 (t, J
= 8.4 Hz, 2H), 6.94 (t, J = 7.0 Hz, 1H), 3.42 (s, 3H); 13C NMR (125
MHz, CDCl3) δ 162.5 (d, JC−F = 245.7 Hz), 147.8, 133.0, 130.7, 129.0,
127.5 (d, JC−F = 7.6 Hz), 120.6, 115.5 (d, JC−F = 21.6 Hz), 115.3, 33.1;
HRMS-EI (70 eV) m/z calcd for C14H14FN2 [M + H]+ 229.1141,
found 229.1134.
(E)-1-Methyl-1-phenyl-2-(1-phenylethylidene)hydrazine (3aq).34
1
52% yield (116 mg); oil; H NMR (500 MHz, CDCl3) 7.92−7.91
(m, 2H), 7.44−7.41 (m, 3H), 7.29−7.26 (m, 2H), 6.97 (d, J = 7.7 Hz,
2H), 6.90 (t, J = 7.3 Hz, 1H), 3.17 (s, 3H), 2.35 (s, 3H); 13C NMR
(125 MHz, CDCl3) δ 165.5, 151.3, 138.3, 129.8, 128.8, 128.4, 126.7,
120.0, 115.5, 42.8, 16.5.
(E)-2-(4-Chlorobenzylidene)-1-methyl-1-phenylhydrazine
(3ah).32 87% yield (212 mg); mp 108−109 °C; 1H NMR (500 MHz,
CDCl3) δ 7.62 (d, J = 8.4 Hz, 2H), 7.43 (s, 1H), 7.37−7.31 (m, 6H),
6.95 (t, J = 7.1 Hz, 1H), 3.41 (s, 3H); 13C NMR (125 MHz, CDCl3) δ
147.7, 135.3, 133.1, 130.3, 129.0, 128.7, 127.1, 120.8, 115.3, 33.1.
(E)-2-(2-Chlorobenzylidene)-1-methyl-1-phenylhydrazine (3ai).
(E)-2-Butylidene-1-methyl-1-phenylhydrazine (3ar). 78% yield
1
(138 mg); oil; H NMR (500 MHz, CDCl3) δ 7.28−7.21 (m, 4H),
6.87−6.81 (m, 2H), 3.20 (s, 3H), 2.37−2.33 (m, 2H), 1.63−1.56 (m,
2H), 1.01−0.97 (m, 3H); 13C NMR (125 MHz, CDCl3) δ 148.4,
136.0, 128.9, 119.7, 114.8, 35.0, 33.0, 20.9, 13.8; HRMS-EI (70 eV) m/
z calcd for C11H17N2 [M + H]+ 177.1392, found 177.1385.
1
83% yield (203 mg); mp 47−48 °C; H NMR (500 MHz, CDCl3)
δ 8.07 (d, J = 8.1 Hz, 1H), 7.77 (s, 1H), 7.37−7.35 (m, 2H), 7.32−
7.28 (m, 3H), 7.23 (t, J = 7.5 Hz, 1H), 7.15−7.11 (m, 1H), 6.94 (t, J =
6.9 Hz, 1H), 3.38 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 147.6,
133.9, 132.6, 129.6, 129.0, 128.3, 128.1, 126.8, 126.2, 120.9, 115.4,
33.2; HRMS-EI (70 eV) m/z calcd for C14H14ClN2 [M + H]+
245.0846, found 245.0841.
(E)-2-Hexylidene-1-methyl-1-phenylhydrazine (3as). 80% yield
1
(163 mg); oil; H NMR (500 MHz, CDCl3) δ 7.28−7.22 (m, 4H),
6.86−6.81 (m, 2H), 3.20 (s, 3H), 2.38−2.34 (m, 2H), 1.60−1.54 (m,
2H), 1.38−1.34 (m, 4H), 0.91 (t, J = 6.8 Hz, 3H); 13C NMR (125
MHz, CDCl3) δ 148.4, 136.2, 128.9, 119.6, 114.8, 33.0, 31.5, 27.3,
22.5, 14.0; HRMS-EI (70 eV) m/z calcd for C13H21N2 [M + H]+
205.1705, found 205.1700.
(E)-2-(4-Bromobenzylidene)-1-methyl-1-phenylhydrazine (3aj).
87% yield (250 mg); mp 125−126 °C; 1H NMR (500 MHz,
CDCl3) δ 7.56 (d, J = 8.6 Hz, 2H), 7.48 (d, J = 8.5 Hz, 2H), 7.42 (s,
1H), 7.38−7.31 (m, 4H), 6.95 (t, J = 7.1 Hz, 1H), 3.42 (s, 3H); 13C
NMR (125 MHz, CDCl3) δ 147.7, 135.8, 131.6, 130.4, 129.0, 127.4,
121.3, 120.9, 115.4, 33.2; HRMS-EI (70 eV) m/z calcd for
C14H13BrN2Na [M + Na]+ 311.0160, found 311.0157.
(E)-1-Methyl-1-phenyl-2-(4-(trifluoromethyl)benzylidene)-
hydrazine (3ak). 81% yield (226 mg); mp 87−88 °C; 1H NMR (500
MHz, CDCl3) δ 7.77 (d, J = 7.0 Hz, 2H), 7.60 (d, J = 7.4 Hz, 2H),
7.48 (s, 1H), 7.40−7.33 (m, 4H), 6.98 (t, J = 6.6 Hz, 1H), 3.45 (s,
3H); 13C NMR (125 MHz, CDCl3) δ 147.6, 140.3, 129.8, 129.1, 129.0
(E)-1-Methyl-2-octylidene-1-phenylhydrazine (3at). 82% yield
1
(191 mg); oil; H NMR (500 MHz, CDCl3) δ 7.20−7.14 (m, 4H),
6.78−6.73 (m, 2H), 3.12 (s, 3H), 2.30−2.26 (m, 2H), 1.48 (quint, J =
7.4 Hz), 1.32−1.18 (m, 8H), 0.81 (t, J = 7.0 Hz, 3H); 13C NMR (125
MHz, CDCl3) δ 148.4, 136.2, 128.9, 119.6, 114.7, 33.0, 32.9, 31.8,
29.2, 29.1, 27.6, 22.6. 14.1; HRMS-EI (70 eV) m/z calcd for C15H25N2
[M + H]+ 233.2018, found 233.2013.
(E)-1-Methyl-2-(3-methylbutylidene)-1-phenylhydrazine (3au).
1
75% yield (142 mg); oil; H NMR (500 MHz, CDCl3) δ 7.28−7.21
(m, 4H), 6.86−6.80 (m, 2H), 3.21 (s, 3H), 2.27−2.24 (m, 2H), 1.88
(heptet, J = 6.8 Hz, 1H), 0.98 (d, J = 6.7 Hz, 6H); 13C NMR (125
MHz, CDCl3) δ 148.4, 135.4, 128.9, 119.7, 114.8, 41.9, 33.1, 27.4,
22.4; HRMS-EI (70 eV) m/z calcd for C12H19N2 [M + H]+ 191.1548,
found 191.1545.
(q, JC−F = 32.1 Hz), 126.0, 125.5 (q, JC−F = 3.1 Hz), 124.3 (q, JC−F
=
270.4 Hz), 121.3, 115.6, 33.3; HRMS-EI (70 eV) m/z calcd for
C15H13F3N2Na [M + Na]+ 301.0929, found 301.0927.
(E)-1-Methyl-1-phenyl-2-(4-(trifluoromethoxy)benzylidene)-
1
hydrazine (3al). 88% yield (259 mg); mp 59−60 °C; H NMR (500
(E)-2-(Cyclohexylmethylene)-1-methyl-1-phenylhydrazine (3av).
MHz, CDCl3) δ 7.70 (d, J = 8.8 Hz, 2H), 7.46 (s, 1H), 7.38−7.31 (m,
4H), 7.21 (d, J = 8.4 Hz, 2H), 6.95 (tt, J = 7.1 Hz and J = 1.3 Hz, 1H),
3.43 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 148.5, 147.7, 135.6,
130.0, 129.0, 127.1, 121.1, 120.9, 120.5 (q, JC−F = 255.4 Hz), 115.4,
33.1; HRMS-EI (70 eV) m/z calcd for C15H14F3N2O [M + H]+
295.1058, found 295.1053.
1
77% yield (167 mg); oil; H NMR (500 MHz, CDCl3) δ 7.27−7.22
(m, 4H), 6.83 (t, J = 7.0 Hz, 1H), 6.71(d, J = 5.0 Hz, 1H), 3.18 (s,
3H), 2.36−2.29 (m, 1H), 1.90−1.88 (m, 2H), 1.81−1.77 (m, 2H),
1.70−1.66 (m, 1H), 1.38−1.20 (m, 5H); 13C NMR (125 MHz,
CDCl3) δ 148.5, 140.3, 128.9, 119.5, 114.6, 41.2, 32.7, 31.3, 26.2, 25.8;
HRMS-EI (70 eV) m/z calcd for C14H21N2 [M + H]+ 217.1705, found
217.1699.
(E)-1-Methyl-2-(naphthalen-1-ylmethylene)-1-phenylhydrazine
1
(3am). 78% yield (202 mg); mp 92−93 °C; H NMR (500 MHz,
(E)-2-Benzylidene-1-methyl-1-(p-tolyl)hydrazine (3ba). 80% yield
(179 mg); mp 81−82 °C; 1H NMR (500 MHz, CDCl3) δ 7.68 (d, J =
7.5 Hz, 2H), 7.45 (s, 1H), 7.36 (t, J = 7.6 Hz, 2H), 7.26 (t, J = 8.0 Hz,
3H), 7.12 (d, J = 8.4 Hz, 2H), 3.40 (s, 3H), 2.31 (s, 3H); 13C NMR
(125 MHz, CDCl3) δ 145.8, 136.9, 131.3, 130.0, 129.5, 128.5, 127.5,
CDCl3) δ 8.66 (d, J = 8.5 Hz, 1H), 8.17 (s, 1H), 7.99 (d, J = 7.3 Hz,
1H), 7.88 (d, J = 8.2 Hz, 1H), 7.79 (d, J = 8.2 Hz, 1H), 7.58−7.55 (m,
1H), 7.52−7.49 (m, 2H), 7.44 (d, J = 8.1 Hz, 2H), 7.35 (t, J = 8.0 Hz,
2H), 6.96 (t, J = 7.3 Hz, 1H), 3.55 (s, 3H); 13C NMR (125 MHz,
CDCl3) δ 148.0, 134.0, 132.1, 130.6, 129.1, 128.7, 128.1, 126.2, 125.6,
F
dx.doi.org/10.1021/jo501161u | J. Org. Chem. XXXX, XXX, XXX−XXX